HANSOH PHARMA

Forecast & Rating22 analysts currently cover HANSOH PHARMA, with about 95.5% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$46.39, about 43.4% upside from the current price of HK$32.34. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 49.2% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study HANSOH PHARMA closely still see room for the stock to rise. Data as of Jul 30, 2026; for reference only and not investment advice.